Observations placeholder
Neulasta
Identifier
019682
Type of Spiritual Experience
Background
A description of the experience
Pegfilgrastim is a PEGylated form of the recombinant human granulocyte colony-stimulating factor (GCSF) analog filgrastim. It serves to stimulate the level of white blood cells (neutrophils)
Pegfilgrastim treatment can be used to stimulate bone marrow to produce more neutrophils to fight infection in patients undergoing chemotherapy.
On Jan, 05, 2017 18,385 people reported to have side effects when taking Neulasta.
Among them, 50 people (0.27%) have Hallucination
Time on Neulasta when people have Hallucination :
< 1 month | 1 - 6 months | 6 - 12 months | 1 - 2 years | 2 - 5 years | 5 - 10 years | 10+ years | |
Hallucination | 100.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Gender of people who have Hallucination when taking Neulasta :
Female | Male | |
Hallucination | 97.50% | 2.50% |
Age of people who have Hallucination when taking Neulasta :
0-1 | 2-9 | 10-19 | 20-29 | 30-39 | 40-49 | 50-59 | 60+ | |
Hallucination | 0.00% | 0.00% | 8.82% | 0.00% | 79.41% | 0.00% | 0.00% | 11.76% |
On Jan, 4, 2016: 9,071 people reported to have side effects when taking Neulasta. Among them, 304 people (3.35%) have Death.
Time on Neulasta when people have Death :
< 1 month | 1 - 6 months | 6 - 12 months | 1 - 2 years | 2 - 5 years | 5 - 10 years | 10+ years | |
Death | 61.11% | 31.48% | 5.56% | 1.85% | 0.00% | 0.00% | 0.00% |
Gender of people who have Death when taking Neulasta :
Female | Male | |
Death | 45.96% | 54.04% |
Age of people who have Death when taking Neulasta :
0-1 | 2-9 | 10-19 | 20-29 | 30-39 | 40-49 | 50-59 | 60+ | |
Death | 0.00% | 0.54% | 1.08% | 0.00% | 1.62% | 9.73% | 18.38% | 68.65% |